GlassScriptPhysician profile
Melchor Gonzalez
NPI 1902806151
$8,132.37
in general payments reported to CMS, 2019-2025
27 companies · $52.52 in 2025
The $52.52 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,858 · 2020: $796 · 2021: $903 · 2022: $387 · 2023: $396 · 2024: $740 · 2025: $52.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863 · Travel and Lodging: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.45 |
| Travel and Lodging | $324.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,869.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $1,342.91 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $696.68 | 2019-2022 | |
| Boston Scientific Corporation | $653.04 | 2019-2020 | |
| Abiomed | $526.05 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $326.44 | 2019-2022 | |
| Amgen INC. | $306.61 | 2019-2022 | |
| Abbott Laboratories | $214.15 | 2019-2023 | Aveir |
| Shockwave Medical, INC | $134.92 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $129.82 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $125.81 | 2023 | C.Cam Imaging System |
| Penumbra, INC. | $101.00 | 2021 | |
| Cordis US Corp. | $99.87 | 2022 | |
| Merck Sharp & Dohme LLC | $96.57 | 2021-2022 | |
| Medtronic, INC. | $72.96 | 2021-2024 | Micra |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $62.09 | 2019 | |
| Cvrx, INC. | $61.06 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $49.05 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $48.16 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $39.85 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $39.31 | 2024 | Optimizer |
| Cardiva Medical, INC. | $30.25 | 2023 | |
| Biotronik INC. | $25.40 | 2020 | |
| Opsens INC. | $24.07 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.50 | 2021 | |
| Vifor Pharma, INC. | $20.30 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melchor Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.